Sociodemographic Factors Associated with Opioid Agonist Treatment Receipt and Retention at an Integrated Safety-Net Health System
- 7 April 2026
- journal article
- Published by Taylor & Francis in Substance Use & Misuse
- Vol. 61 (13) , 1-9
Abstract
Sociodemographic differences in opioid use disorder (OUD) treatment engagement have implications for population health. Continuum of care models can guide the opioid epidemic response by identifying differences in treatment patterns. We evaluated one such model at an integrated, safety-net health system in Denver, Colorado and examined the association of patient characteristics with opioid agonist treatment (OAT) receipt and retention. We identified a cohort of patients with OUD from 2023 to 2024 from electronic health records. We used multivariable regression to estimate the association of sociodemographic and health factors with OAT receipt and 90-day retention. Of 8,954 patients with OUD, 40% received OAT and 40% of those were retained on OAT at 90 days. Non-Hispanic Black patients and those with co-occurring alcohol use disorder had a lower likelihood of OAT receipt (Risk Ratio [RR] vs non-Hispanic White 0.68, 95% CI: 0.62-0.76; RR vs no alcohol use disorder: 0.88, 95% CI: 0.83-0.32). Patients without insurance and young adults aged 18-24 years had a lower likelihood of OAT receipt and retention. Those with co-occurring mental health conditions had a higher likelihood of OAT receipt and retention. Co-occurring stimulant use disorder, age 55+, and medical comorbidities had differential associations between OAT receipt and retention. Associations between patient characteristics and OAT receipt and retention suggest three patterns: cumulative disadvantage with factors associated with both lower treatment and retention; uneven disadvantage for factors associated with either decreased treatment or retention; and inverse associations wherein factors showed benefit in one stage but disadvantage in the other.Keywords
This publication has 34 references indexed in Scilit:
- A learning health system model for addressing substance use: Denver Health Center for Addiction MedicineLearning Health Systems, 2025
- Use of Medications for Opioid Use Disorder in Older AdultsAmerican Journal of Preventive Medicine, 2025
- Improving Identification of Patients Experiencing Homelessness in the Electronic Health Record: A Curated Registry ApproachJournal of General Internal Medicine, 2024
- Multilevel Factors Impacting Substance Use Treatment Access, Engagement, and Racial Equity Among Opioid Overdose Survivors in Boston, MAJournal of General Internal Medicine, 2024
- Racial‒Ethnic Disparities of Buprenorphine and Vivitrol Receipt in MedicaidAmerican Journal of Preventive Medicine, 2022
- Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 PandemicJAMA Health Forum, 2022
- Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid DependenceJAMA Psychiatry, 2021
- Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured PatientsJAMA Network Open, 2020
- Monitoring opioid addiction and treatment: Do you know if your population is engaged?Drug and Alcohol Dependence, 2019
- Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006–2016Drug and Alcohol Dependence, 2018